PNC Financial Services Group’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.09K Sell
363
-7,104
-95% -$94.5K ﹤0.01% 4595
2026
Q2
$109K Buy
7,467
+11
+0.1% +$145 ﹤0.01% 2867
2026
Q1
$103K Buy
7,456
+2,785
+60% +$42K ﹤0.01% 2800
2025
Q4
$84.2K Buy
4,671
+170
+4% +$3.05K ﹤0.01% 2909
2025
Q3
$83.4K Buy
4,501
+2,403
+115% +$37.8K ﹤0.01% 2925
2025
Q2
$33.6K Buy
2,098
+1,998
+1,998% +$35.6K ﹤0.01% 3332
2025
Q1
$1.94K Buy
+100
New +$2.1K ﹤0.01% 4354

Other funds holding CLBT

PNC Financial Services Group's CLBT Position: Q3 2026 in Review

PNC Financial Services Group reduced its Cellebrite (CLBT) stake by 95% in Q3 2026, selling an estimated $94.5K and leaving 363 shares worth $4.09K. The position accounts for ﹤0.01% of the portfolio, ranked #4595.

PNC Financial Services Group first reported a position in CLBT in Q1 2025 and has held it in 7 quarters since. The position peaked at $109K in Q2 2026. 198 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

  • PNC Financial Services Group held 363 shares of Cellebrite worth $4.09K as of Q3 2026.
  • PNC Financial Services Group sold 7,104 Cellebrite shares in Q3 2026, an estimated $94.5K.
  • Cellebrite made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4595 holding.
  • PNC Financial Services Group first reported a position in Cellebrite in Q1 2025 and has held it in 7 quarters since.
  • PNC Financial Services Group's Cellebrite position peaked at $109K in Q2 2026.
  • 198 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.